Ways of optimizing diuretic therapy in chronic congestive heart failure, place of torasemide prolonged release

Kobalava Zh.D. ¹ , Kiyakbaev G.K. ¹

КАРДИОЛОГИЯ

KlinMed Consulting

4

Русский

69-77

Опубликовано

54

2014

• ¹ Russian University of Peoples Friendship, ul. Mikluho-Maklaya, 6, 117198 Moscow, Russian Federation

diuretic agent; loop diuretic agent; sulfonamide; torasemide; classification; conference paper; delayed release formulation; dose response; drug monitoring; heart failure; human; outcome assessment; pathophysiology; randomized controlled trial (topic); Delayed-Action Preparations; Diuretics; Dose-Response Relationship, Drug; Drug Monitoring; Heart Failure; Humans; Outcome Assessment (Health Care); Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides

19.10.2018

08.02.2022

https://repository.rudn.ru/ru/records/article/record/4873/